ATR and neoplasm: This specificity explains why these agents fail to exert efficacy in most solid tumors—without pre-existing DDR dependency, the untargeted non-DDR functions of ATR cannot be exploited to induce tumor cell death, and redundant DDR networks further compensate for ATR inhibition.